The research team led by Dr. Jeong Min Park from the Nano Materials Research Division at the Korea Institute of Materials Science (KIMS) has successfully developed a new high-performance metal 3D-printed alloy tailored for space environments.
The Johns Hopkins University and Johns Hopkins Medicine, together with descendants of Henrietta Lacks, broke ground today on the future site of the building named in honor of Mrs. Lacks, the Baltimore County woman whose HeLa cells have contributed to medical advancements around the world.
Kidney Week 2024: Live Event
Negative emotions may help explain the link between insomnia and dangerous drinking, according to a small study involving veterans with Alcohol Use Disorder (AUD). The findings provide new insight into why insomnia might be linked AUD. Insomnia symptoms are highly prevalent in people with substance use disorders (SUDs). Among veterans with AUD, for example, almost 2 in 3 experience insomnia.
Among 88,183 U.S. high school students, marijuana use declined from 23.1% in 2011 to 15.8% in 2021, with first-time use before age 13 dropping from 8.1% to 4.9%. In 2021, use was highest among 12th graders (22.4%) and 11th graders (18.7%). Notably, girls (17.8%) surpassed boys (13.6%) in reported use in 2021, reversing past trends. While Asian, Hispanic, and white adolescents saw declines, Black adolescents had a higher usage rate of 20.5% in 2021, indicating ongoing racial disparities.
A new international trial is investigating the efficacy and safety of gene therapy in patients with Hurler syndrome and will compare results of gene therapy against BMT which is the current standard of care. UCSF Benioff Children’s Hospitals are among three sites in the U.S. and seven in the world now enrolling patients for the clinical trial.
PNNL researchers are developing a new approach to explore the higher-dimensional shape of cyber systems to identify signatures of adversarial attacks.
Digital Science is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having on academics and their institutions.
Tulane University will host the Tulane Future of Energy Forum in New Orleans on Nov. 13-15. The forum, which is free and open to the public, will bring together global leaders to discuss innovative strategies for meeting energy demands while transitioning to a lower-carbon future. This year’s theme, Can Energy Pragmatism Secure Our Energy Future?, will focus on practical solutions, featuring high-caliber speakers, cutting-edge research and opportunities to engage with key decision-makers across the energy sector.
The research team of Dr. Byeongjin Park and Dr. Sang Bok Lee at the Korea Institute of Materials Science (KIMS), has developed the world's first ultra-thin film composite material capable of absorbing over 99% of electromagnetic waves from various frequency bands (such as 5G/6G, WiFi, and autonomous driving radar) using a single material.
Gastroenterologists and other GI health care professionals will convene at the Pennsylvania Convention Center in Philadelphia, PA, for the premier clinical gastroenterology event—the American College of Gastroenterology’s 89th Annual Scientific Meeting and Postgraduate Course (ACG 2024).
Dr. Roy-Chaudhury will head up an organization—with nearly 21,000 health professionals representing 140 countries—dedicated to leading the fight against kidney diseases.
This year’s lectures highlight time and process management for physicians, leveraging networks for clinical research, innovations in endoscopy, kindness-influenced trust and healing, and personal and professional opportunities in Africa.
Adults aged 35 to 60 are drinking at unprecedented rates, with those who binge drank in high school reporting more past 30-day high-risk drinking in midlife. And this link may be especially strong for women, according to a study just published in Alcohol: Clinical and Experimental Research Health. These trends are particularly concerning as health conditions, and biological processes common with aging put adults in midlife at greater health risk from alcohol use.
El alergista James Tracy, DO (Doctor en Medicina Osteopática), de Omaha, NE, fue instalado como presidente del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) en la Reunión Científica Anual del ACAAI el 27 de octubre en Boston. La alergista Cherie Zachary, MD, de Eagan, Minnesota, fue elegida presidenta electa del ACAAI.
Allergist James Tracy, DO, of Omaha, NE, was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the ACAAI Annual Scientific Meeting on October 27 in Boston. Allergist Cherie Zachary, MD, of Eagan, MN, was elected ACAAI president-elect.
Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant recipients’ kidney function in a phase 2 trial. Investigators now have data from a phase 3 trial with clazakizumab. The findings from the Phase 3 IMAGINE trial, the largest placebo-controlled study in kidney transplant recipients with caAMR, will be presented at ASN Kidney Week 2024 October 23– 27.
For kidney transplant recipients experiencing antibody-mediated rejection, the current standard of care involves removing donor-specific antibodies (DSAs) through plasmapheresis (PLEX)—a procedure that removes antibodies from the plasma portion of the blood. Results from a recent clinical trial reveal that an investigational drug called imlifidase, which cleaves and inactivates the type of antibodies that include DSAs, is more effective than PLEX. The research will be presented at ASN Kidney Week 2024 October 23–27.
IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition’s pathogenesis. Investigators have developed and tested a novel gene therapy that enters kidney cells and enables them to block complement activation. The research will be presented at ASN Kidney Week 2024 October 23– 27.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
